Section Arrow
CLDX.NASDAQ
- Celldex Therapeutics
Quotes are at least 15-min delayed:2024/05/16 14:31 EDT
Last
 39.785
-0.385 (-0.96%)
Day High 
40.2575 
Prev. Close
40.17 
1-M High
43.35 
Volume 
534.68K 
Bid
39.76
Ask
39.8
Day Low
39.42 
Open
40.03 
1-M Low
35.65 
Market Cap 
2.65B 
Currency USD 
P/E -- 
%Yield
10-SMA 40.92 
20-SMA 39.29 
50-SMA 40.87 
52-W High 53.18 
52-W Low 22.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.86/-2.69
Enterprise Value
2.65B
Balance Sheet
Book Value Per Share
12.72
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.88M
Operating Revenue Per Share
0.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.0996+0.0219+28.19%-- 
NBYNovaBay Pharmaceuticals0.1208+0.0163+15.60%-- 
DNAGinkgo Bioworks Holdings0.82675-0.01235-1.47%-- 
JAGXJaguar Health0.282+0.0269+10.54%-- 
NVAXNovavax14.3101+1.4101+10.93%-- 
Quotes are at least 15-min delayed:2024/05/16 14:31 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.